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Background:Whilst there is a presumption inmedicine that ageing adversely affects cardiovascular function, it is
unknown if resting haemodynamics are compromised in the elderly, and if so, to what degree. This study was
intended to answer several questions; whether age-related changes in haemodynamics occur; whether there
was a difference between the haemodynamics of ageing subjects with andwithoutmild chronic disease; wheth-
er there was a difference in haemodynamics as measured from either the aortic or the pulmonary valve; and to
establish reference ranges for this population.
Methods: Chinese adults aged over 60 years were divided into three age bands of 61–70, 71–80 and over
80 years. The haemodynamic parametersweremeasured using a non-invasive Doppler ultrasound-based instru-
ment, the Ultrasonic Cardiac Output Monitor (USCOM).
Results: One hundred and sixty-ﬁve subjects (48.5% males) were recruited. 78 (47.3%) had no known disease
whilst 87 (52.7%) had mild chronic illness. A total of 21 individual haemodynamic parameters were measured
or calculated for each subject. There were no signiﬁcant differences in stroke volume (SV), cardiac output
(CO), systemic vascular resistance (SVR) or in body surface area (BSA)-indexed parameters, SV index (SVI), car-
diac index (CI) and SVR index (SVRI) across age groups, or in other indexed haemodynamic parameters. No sig-
niﬁcant differences in indexed haemodynamics were found between those subjectswith and thosewithoutmild
chronic disease. Small, statistically signiﬁcant, but clinically insigniﬁcant, differences (b5%) were found between
the aortic and pulmonary valve measurements for SV, SVI and heart rate.
Conclusions: Ageing does not have any signiﬁcant effect on resting haemodynamics in the elderly population
studied. Mild chronic disease does not adversely affect resting haemodynamics in this population.
General Signiﬁcance: Reference ranges were established for 21 haemodynamic parameters, as measured by
USCOM, for an elderly Chinese population but not for non-Chinese populations.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Population ageing is widespread around the world. The ageing
trend began in developed countries and is now accelerating, not
only in the ﬁrst world, but also in developing countries. The major
drivers of population ageing are increasing longevity and declining
fertility [5]. The Chinese population is ageing particularly rapidly
due to a falling mortality rate and the one child policy. By 2050
more than one quarter of the population will be over 65 years olddicine Academic Unit, 2/F,Main
l, Shatin, NT, Hong Kong Special
2648 1469.
), thrainer@cuhk.edu.hk
. This is an open access article under[1]. Whilst ageing is known to affect the cardiovascular system both
structurally and functionally [21,25], it is still unclear how, or if, age-
ing affects the resting haemodynamic proﬁles of the elderly.
The Ultrasonic Cardiac Output Monitor (USCOM) is a non-
invasive continuous wave Doppler ultrasound device derived from
echocardiography, which measures haemodynamic parameters, ac-
curately and reliably [8,10,23,27,32,37]. It allows the measurement
of haemodynamics in normal conscious subjects in a totally non-
invasive manner, by measuring transvalvular ﬂow across either the
aortic or the pulmonary valve. It has been shown to be more accurate
and more sensitive to change than the pulmonary artery catheter
[32], and at least as accurate as research quality echocardiography
[16,30], with a much shorter learning curve than echocardiography
[15,26,27]. As with all quantitative tests, it is essential to have a ref-
erence range to compare any given reading against. By deﬁnition,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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clinically. Equally, from a prognostic viewpoint, knowledge of the
normal range is required to establish goals of therapy. Reference
ranges for haemodynamic parameters as measured by USCOM have
been established for Chinese full-term neonates [16,17], Chinese
children aged 1 month–12 years [8], Chinese and Caucasian adoles-
cents aged between 12 and18 years [18], and Chinese and Caucasian
adults aged between 18 and 60 years (unpublished data). However,
there are no reference ranges for the elderly, despite the increasing
use of point of care haemodynamics in general, and the USCOM in
particular, in clinical practice. It is also unknown to what degree
mild chronic disease, prevalent in the elderly population, affects
resting haemodynamics.
This studywas undertaken to establishwhether age-related changes
in haemodynamics occur; towhat degree the haemodynamics of ageing
subjects are affected by mild chronic disease; whether there is any dis-
crepancy inmeasurements between the aortic valve and the pulmonary
valve in this age group; and to establish reference ranges for this
population.
2. Methods
2.1. Study design
This was a prospective cross-sectional study conducted between
February and October 2012 in the Emergency Department of the
Prince of Wales Hospital, Hong Kong. All aspects of the study were
approved by the Joint Chinese University of Hong Kong–New Terri-
tories East Cluster Clinical Research Ethics Committee (reference
number CRE-2009.482). Chinese adults aged over 60 years were re-
cruited through Ma On Shan Neighbourhood Elderly Centre, the De-
partment of Otorhinolaryngology, Head and Neck Surgery of Prince
of Wales Hospital, and volunteers' referrals from other districts in
Hong Kong. Exclusion criteria included age under 61 years, lack of
consent, non-Chinese adults, and acute illness within the past four
weeks. Following a detailed explanation of the study, written con-
sent was obtained from all recruited subjects. Each subject was re-
quested to complete a health questionnaire to identify current and
past health status, and current medication use. Clinical management
systems were also used to cross reference data from the subjects'
medical records, where available.
Subjects were divided into two groups. Group 1 included those
with no known acute or chronic illness, and who had taken no med-
ication in the previous four weeks, and would be classed as ASA 1 (a
normal healthy subject) according to the classiﬁcation of the
American Society of Anesthesiology [2]. Group 2 included subjects
categorized as ASA 2, a patient with mild systemic disease. Subjects
with more severe chronic disease, corresponding to ASA 3 and
above, were excluded.
Physical characteristics of all subjects were recorded. Standing
height was measured barefoot to the nearest 0.1 cm using a mea-
suring tape. Body weight was measured to the nearest 0.1 kg
using an electronic scale (Compact Precision Scale C200H, Conair
Far East Ltd., Hong Kong). Arterial pressure was measured in the
right arm in the supine position with an appropriately sized cuff
using an oscillometric device (Omron HEM-7200 Automatic Blood
Pressure Monitor, Omron Healthcare Co., Ltd, Japan), followed im-
mediately by the USCOM measurement. Haemoglobin concentra-
tion was measured with a capillary blood sample collected by
ﬁnger prick using HemoCue® B-Hemoglobin system (HemoCue®
AB, Ängelholm, Sweden).
2.2. USCOM measurements
The USCOM device (USCOM Ltd, Sydney, Australia) calculates
stroke volume (SV) by measuring the ejection velocity of bloodﬂow across the aortic or pulmonary valves and multiplying the ve-
locity time integral (VTI) of the trace of the Doppler ﬂow proﬁle by
the cross-sectional area (CSA) of the minimum outﬂow tract diam-
eter (OTD), which is derived from the subject's weight and height
using a proprietary algorithm. Heart rate (HR) is also measured
from the periodicity of the Doppler waveform, and cardiac output
calculated as CO = SV × HR. The mean arterial pressure (MAP) is
calculated from the inputted systolic and diastolic blood pressures
as MAP = DBP + [(SBP − DBP) / 3] and systemic vascular resis-
tance (SVR) from CO, MAP and central venous pressure (CVP) as
SVR = (MAP − CVP) × 80 / CO. CVP was assumed to be zero
[20].
The USCOM uses measured oxygen saturation (SpO2) from an in-
tegral pulse oximeter probe and inputted haemoglobin concentra-
tion [Hb] to calculate oxygen delivery (DO2). Smith–Madigan
inotropy index (SMII) and potential to kinetic energy ratio (PKR)
are calculated using the method of Smith and Madigan [35]. The 21
haemodynamic parameters are explained further in Appendix 1
[19,35].
All USCOM measurements were performed by a senior research-
er with experience of over 1000 USCOM examinations in a wide va-
riety of patients and research subjects. To achieve acceptable
proﬁciency in the use of the USCOM, trainees must achieve a
level of inter- and intra-observer variability which is within the
limits of physiological variation of patients, i.e. less than 10%, and
typically the values are around 5–8% [9,14,16]. Measurements
were performed with the subject in the supine position, following
a period of rest of at least 5 min, and immediately following
blood pressure measurement. The suprasternal insonation window
was used for aortic measurements, which was performed ﬁrst,
whilst the left parasternal insonation window was used for pulmo-
nary valve measurements. A minimum of three consecutive diag-
nostic quality Doppler ejection proﬁles were required for each
measurement, and three measurements were made for each sub-
ject on each of the two valves. This generated a minimum of 18 di-
agnostic quality ejection waveforms for each subject, nine for each
valve. This leads to a threefold improvement in measurement accu-
racy, as the standard error of the measurement is directly propor-
tional to the standard deviation of SV and inversely proportional
to the square root of the number of measurements, in this case
√9 = 3. This provides a greater degree of measurement accuracy
than the single waveform examination often employed in
echocardiography.
2.3. Sample size calculation
Based on published values [6], the mean SV for subjects aged 65
and 73 years were 69.5 ± 4.9 mL and 63.0 ± 4.7 mL respectively.
Therefore, a minimum sample size of 9 subjects in each group
would be required to achieve a power of 80% with a 2-sided signiﬁ-
cance level of α= 0.05. In order to investigate the difference in hae-
modynamic parameters between the three age groups, the two ASA
groups and the two aortic and pulmonary windows, the minimum
sample size required for this study is 108 subjects (9 × 3 age groups
× 2 ASA groups × 2 valves = 108). From previous experience with
this population, we estimated that up to 25% of subjects might
yield sub-optimal quality images. The minimum sample size was
therefore set at 135.
2.4. Statistical analysis
Continuous variables were analyzed using the Mann–Whitney
U test or Wilcoxon Rank Sum test. Multiple comparisons of differ-
ent age groups were performed using the Kruskal–Wallis test. Cat-
egorical variables were analyzed using the Chi-square test or
Fisher's exact test. As the data showed a normal distribution, the
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to include the central 95% of the population. The data were
analysed using PASW Statistics v18.0 (SPSS Inc., IBM Corporation,
Chicago, IL) and MedCalc version 11.5.1.0 (MedCalc Software,
Mariakerke, Belgium). A P value of b0.05 was regarded as statisti-
cally signiﬁcant. Data are presented as median, 2.5th and 97.5th
percentiles, 95% conﬁdence intervals, and mean with standard de-
viations as appropriate. Frequencies are expressed as counts and
percentages.
3. Results
One hundred and sixty ﬁve subjects (48.5% males) were enrolled
in the study. 77 subjects (46.4%) were able to be checked through
clinical management systems to cross reference data. 78 subjects
(47.3%) had no known disease, the ASA 1 group, whilst 87 (52.7%)
had mild chronic illness, the ASA 2 group. This group included one
subject (1.1%) with an irregular heartbeat, 65 (74.8%) with hyper-
tension, 18 (20.6%) with diabetes, 30 (34.4%) with hypercholesterol-
emia, and 14 (16.1%) with a history of cancer but no recurrence or
need for treatment within the last 10 years, but who could be ex-
pected to have mild systemic disturbance caused by this or another
pathological process [2].
The demographic data for all subjects are shown in Table 1. For
healthy subjects (ASA 1), the 71–80 years group had signiﬁcantly lower
body weight (P = 0.029) and body surface area (BSA) (P = 0.015)
than for subjects of b71 years and N80 years. Compared to the ASA 2
group, ASA 1 subjects aged 61–70 years had signiﬁcantly lower SBP
(P = 0.045), and those aged 71–80 years had signiﬁcantly lower body
weight (P = 0.003), BSA (P = 0.008) and body mass index (BMI)
(P b 0.001). ASA 1 subjects aged over 80 years were signiﬁcantly
taller than their ASA 2 counterparts (P = 0.007), and had higher BSA
(P = 0.019).
Table 2 shows the SV, CO, SVR and respective index values for all
subjects by age groups. ASA 1 patients aged 61–70 showed a slightly
higher SV in comparison to their ASA 2 counterparts at 84.8 (80.8–
89.7) mL vs. 79.0 (77.2–85.0) mL (P = 0.047). Otherwise, there were
no signiﬁcant differences in any of the parameters between the ASA 1
and ASA 2 groups, or between any age groups within or between ASA
groupings.
The data for both the aortic and pulmonary valve-derived values for
ASA 1 subjects are shown in Table 3. HR, VTI, peak ejection velocity
(Vpk), the mean pressure gradient (Pmn) and minute distance (MD)
were signiﬁcantly higher in aortic measurements whilst SMII, PKR, SV,
SVI and stroke work (SW) were signiﬁcantly higher in pulmonary
measurements.
The comparison data for both ASA 1 female and male patients is
shown in Table 4. CI, Pmn, MD, Vpk, SVI and VTI were all signiﬁcantly
higher in females, whilst PKR and SVRI were signiﬁcantly higher in
males.
4. Discussion
Echocardiography is a standard technique which has been used
for many years to provide data on both cardiac morphology and
haemodynamics. It has come to be regarded as a clinical gold stan-
dard for anatomical evaluation and is often used to evaluate
haemodynamics clinically. However, echocardiography requires
extensive training, particularly for accurate haemodynamic mea-
surements [34]. The largest source of error in haemodynamic mea-
surements with echocardiography stems from difﬁculty in
measuring the aortic and pulmonary outﬂow diameters. The
American Society of Echocardiography recommends that the
average of a minimum of three measurements should be used for
the aortic diameter, and more than this for the pulmonary diame-
ter. In addition, conventional echocardiography generally usespulsed-wave Doppler (PWD) to measure the ﬂow velocity and cal-
culate VTI. Evidence suggests that this is less accurate than using
continuous-wave Doppler (CWD). The current standard of care
recommends the use of a non-imaging probe and the use of
CWD [31,34]. The USCOM predicts the diameter of the aortic and
pulmonary valves based on a proprietary algorithm which is sim-
ilar to the equations described by Nidorf et al. [28]. Measurement
of VTI is largely automated that enables several ejection wave-
forms to be measured in real time and can then be averaged. A
typical examination takes less than 3 min. As a result, USCOM is
simpler and more practical to use, yet provides high quality
beat-to-beat haemodynamic measurements that are at least com-
parable if not better than echocardiography [16,22,30]. Inter-
observer variability is signiﬁcantly lower than echocardiography,
ranging from 5.1 to 17%, [8,9,23] indicating minimal user depen-
dency. As with echocardiography, SV is calculated from VTI and
CSA. Multiplying this by HR yields CO, and further calculations
based on MAP, [Hb], ejection velocities and time measurements
yield further derived parameters. BSA is calculated from input
height and weight data and this is used to calculate index values
for each parameter [19].
As the data was normally distributed, normal ranges can be de-
ﬁned for the population (Tables 3 and 4). Reference ranges for hae-
modynamic parameters are essential for both diagnosis and
guidance of therapy. Haemodynamic parameters outside the refer-
ence range indicate an increased probability of illness, whilst treat-
ment should logically aim to bring those parameters back towards
the reference ranges. The paediatric advanced life support (PALS)
guidelines for example, now specify a target CI value of 3.3 to
6.0 L/min/m2 as a resuscitation goal [7].
In this study, we found that there was no signiﬁcant change in
resting haemodynamic parameters with increasing age in subjects
both with and without known chronic disease. Similar ﬁndings
have been reported previously [11,33]. Left ventricular systolic func-
tion remains relatively well preserved and left ventricular ejection
fraction, SV and CO at rest did not change signiﬁcantly with ageing
[11,33]. Although the ASA 1 subjects aged 61–70 years had slightly
higher SV than ASA 2, the difference, after indexing to body surface
area (SVI), was not signiﬁcant.
In our study the mean CI was 3.3 L·min−1.m−2, which was
higher than those of the elderly subjects reported by Australian
(3.0 L·min−1·m−2) [36], Swedish (2.4 L·min−1·m−2) [3,4] and
American (2.0 L·min−1·m−2) [24] studies. This may be due to
methodological differences or may reﬂect different levels of adipos-
ity between differing populations. Studies have shown that the
United States has the highest obesity rate amongst adults (33.8%),
followed by Australia (24.6%) and Sweden (11.2%), whilst China
has the lowest obesity rate (2.9%) amongst these countries [12,29].
Curiously, the magnitude of CI is similar to that of life expectancy
across the races. Amongst these countries, CI and life expectancy is
highest in Chinese and lowest in Americans. The current life expec-
tancy at birth in Hong Kong is higher than that in Australia,
Sweden and the United States [38].
In our previous studies, CI was highest in Chinese children aged
1 month–12 years (n= 1197; CI= 4.8 L·min−1·m−2) [8], followed
by Chinese adolescents aged between 12 and 18 years (n = 362;
CI = 4.2 L·min−1·m−2) [18], and Chinese adults aged between 18
and 60 years (n = 510; CI = 3.2 L·min−1·m−2) (unpublished
data). The CI was similar in Chinese adults aged below 60 years and
those over 60 years, with a lower SVI (43.7 mL·m−2) but a higher
HR (73 bpm) in those aged below 60 years. This is at variance with
Australian and American studies which showed that mean CI was
lower in the elderly compared with younger adults [24,36]. Whilst
it may appear surprising that resting cardiovascular function in el-
derly Chinese is of a similar level to that of young adults, this may re-
ﬂect differences in adaptive processes that occur with ageing,
Table 1
Characteristics of study participants.
Variables
(median and 95% CI)
Subjects without chronic disease
n = 78
Pa Subjects with chronic disease
n = 87
Pa Pb
Age (years)
Overall 69.0 (67.0–72.0) b0.001 72.0 (70.0–74.0) b0.001 0.080
61–70 years 65.0 (64.0–65.0) 65.0 (64.0–66.8) 0.646
71–80 years 73.0 (72.0–75.6) 74.0 (73.0–74.3) 0.753
N80 years 82.0 (81.1–86.7) 84.5 (82.0–87.0) 0.413
Males, n (%)
Overall 43 (55.1) 0.152 37 (42.5) 0.418 0.144
61–70 years 24/41 (58.5) 14/35 (40.0) 0.167
71–80 years 12/28 (42.8) 18/36 (50.0) 0.752
N80 years 7/9 (77.7) 5/16 (31.3) 0.069
Height (m)
Overall 158.9 (155.5–162.5) 0.058 155.0 (152.0–159.0) b0.001 0.038 ⁎
61–70 years 160.0 (156.7–166.1) 157.0 (154.5–162.0) 0.100
71–80 years 154.5 (151.5–162.8) 157.5 (152.7–161.5) 0.978
N80 years 159.0 (153.1–162.6) 148.0 (144.0–151.7) 0.007 ⁎
Weight (kg)
Overall 55.3 (53.0–60.6) 0.029 58.0 (55.0–61.0) 0.027 0.283
61–70 years 59.9 (53.2–65.2) 58.8 (54.7–63.9) 0.972
71–80 years 51.7 (47.0–57.2) 59.4 (54.8–64.8) 0.003 ⁎
N80 years 55.5 (54.0–65.2) 52.3 (45.2–59.2) 0.053
BSA (m2)
Overall 1.56 (1.50–1.65) 0.015 1.57 (1.53–1.61) 0.003 0.718
61–70 years 1.63 (1.50–1.73) 1.60 (1.53–1.70) 0.766
71–80 years 1.48 (1.42–1.60) 1.58 (1.52–1.71) 0.008 ⁎
N80 years 1.56 (1.52–1.71) 1.45 (1.35–1.55) 0.019 ⁎
BMI (kg/m2)
Overall 22.7 (21.3–23.4) 0.102 24.2 (23.5–25.2) 0.513 0.002 ⁎
61–70 years 23.4 (21.2–23.9) 23.6 (22.9–25.3) 0.215
71–80 years 21.5 (20.5–23.1) 24.3 (23.2–26.1) b0.001 ⁎
N80 years 23.4 (21.7–25.3) 23.2 (21.2–26.4) 0.913
MAP (mm Hg)
Overall 96.4 (93.8–99.3) 0.664 97.2 (95.0–100.9) 0.769 0.151
61–70 years 96.3 (88.1–100.5) 98.2 (94.2–105.3) 0.120
71–80 years 96.5 (93.9–101.9) 96.3 (93.4–101.9) 0.620
N80 years 95.3 (90.6–116.8) 94.0 (89.3–113.0) 0.874
SBP (mm Hg)
Overall 138.0 (134.0–141.1) 0.097 141.0 (138.9–147.1) 0.146 0.004 ⁎
61–70 years 138.0 (130.0–139.5) 141.0 (135.2–147.0) 0.045 ⁎
71–80 years 136.5 (132.7–150.3) 143.5 (135.7–156.0) 0.127
N80 years 149.0 (134.0–177.9) 148.0 (138.3–177.7) 0.423
DBP (mm Hg)
Overall 74.5 (71.9–79.1) 0.832 74.0 (71.0–77.0) 0.007 0.697
61–70 years 75.0 (70.8–80.5) 78.0 (77.0–80.8) 0.326
71–80 years 74.5 (71.4–80.3) 72.5 (69.7–75.3) 0.404
N80 years 73.0 (63.8–82.7) 69.0 (63.6–78.8) 0.728
Heart rate (bpm)
Overall 63.4 (60.4–65.8) 0.115 63.3 (62.0–65.2) 0.315 0.985
61–70 years 62.9 (58.4–65.5) 63.9 (55.7–69.8) 0.540
71–80 years 66.6 (62.7–71.6) 62.4 (59.5–64.9) 0.161
N80 years 58.7 (52.9–66.1) 64.2 (60.3–71.2) 0.562
Legend to Table 1.
Variables are quoted as medians and 95% conﬁdence intervals.
a Comparison between age groups.
b Comparison between subjects without (ASA 1) and with (ASA 2) chronic disease.
⁎ = statistically signiﬁcant.
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4.1. Aortic versus pulmonary measurements
Heart rate was signiﬁcantly higher in the aortic approach than in
the pulmonary approach, whilst SV and SVI were signiﬁcantly lower.
As CO = SV × HR, the net result was that CO and CI were similar for
both approaches. This may represent some degree of anxiety-
induced tachycardia during the aortic measurements which were
performed ﬁrst, which settled over the following few minutes prior
to the pulmonary measurements being made. As the heart rateslows, so diastolic ventricular ﬁlling and stroke volume both in-
crease, resulting in similar cardiac outputs between the two mea-
surements. It is striking that the percentage differences in HR, SV
and SVI between the aortic and pulmonary approaches were only
around 5% and that the measurements of CO and CI showed less
than a 3% difference for the two approaches.
The differences between the aortic and pulmonary values for
Pmn, MD, Vpk and VTI are not surprising. Aortic Pmn, MD, Vpk and
VTI were also found to be higher than pulmonary values in
Australians [36]. The aortic valve is a higher pressure-lower diameter
structure than the pulmonary valve, with the latter having a diame-
ter approximately 11% greater than the aortic valve, and a cross-
Table 3
Haemodynamic parameter values for both aortic and pulmonary valve measurements in subjects without chronic disease (ASA 1) (n = 78).
Parameter Unit Overall Aortic approach Pulmonary approach P
Preload
FT ms 405 (329–456) 396 (321–462) 402 (330–449) 0.326
FTc ms 413 (355–471) 414 (356–474) 412 (346–475) 0.627
SVV % 17.0 (10.7–30.6) 18.0 (8.9–37.7) 16.6 (8.0–30.6) 0.148
Contractility
HR bpm 63.4 (48.9–88.1) 65.0 (47.3–89.4) 61.9 (47.6–85.8) 0.000 ⁎
VTI m 28.9 (20.5–37.8) 30.0 (22.9–41.1) 26.2 (20.8–38.3) 0.000 ⁎
Vpk m·s−1 1.1 (0.9–1.5) 1.2 (1.0–1.7) 1.1 (0.8–1.5) 0.000 ⁎
ET % 42.4 (34.1–52.3) 42.5 (33.3–52.5) 41.8 (32.4–54.5) 0.093
SV mL 82.6 (53.9–112.9) 79.7 (59.2–111.3) 83.9 (62.3–120.0) 0.001 ⁎
SVI mL·m−2 53.6 (35.5–70.4) 50.6 (36.6–70.2) 53.5 (37.8–77.3) 0.001 ⁎
SMII W·m−2 1.8 (1.1–2.4) 1.8 (1.2–2.5) 1.9 (1.2–2.6) 0.022 ⁎
Pmn mm Hg 2.3 (1.3–3.9) 2.7 (1.7–4.6) 2.0 (1.1–4.0) 0.000 ⁎
MD m·min−1 18.0 (13.0–26.0) 19.4 (13.5–28.3) 16.2 (12.0–26.6) 0.000 ⁎
SW mJ 1067 (676–1622) 1031 (633–1531) 1072 (720–1758) 0.002 ⁎
CP W 1.1 (0.7–1.6) 1.1 (0.7–1.7) 1.1 (0.7–1.8) 0.054
Afterload
PKR 44.7 (24.6–77.0) 35.9 (20.7–62.1) 48.2 (23.9–82.3) 0.000 ⁎
SVR d·s·cm−5 1481 (980–2106) 1446 (1036–2301) 1486 (902–2094) 0.157
SVRI d·s·cm−5 m2 2515 (1527–3507) 2486 (1542–3498) 2390 (1321–3478) 0.124
Tissue perfusion
CO L·min−1 5.2 (3.6–7.3) 5.2 (3.5–7.2) 5.2 (4.0–8.1) 0.070
CI L·min−1.m−2 3.2 (2.3–4.7) 3.2 (2.2–4.9) 3.3 (2.4–5.6) 0.081
DO2 mL·min−1 786 (493–1232) 802 (422–1171) 817 (540–1316) 0.074
DO2I mL·min−1 m−2 520 (356–856) 528 (305–817) 515 (357–920) 0.099
Legend to Table 3.
Data presented as medians (2.5th–97.5th percentiles).
⁎ = statistically signiﬁcant.
Table 2
Stroke volume (SV), cardiac output (CO), systemic vascular resistance (SVR) and the corresponding index values for both groups.
Parameters
median (2.5th–97.5th percentiles)
Subjects without chronic disease
n = 78
Pa Subjects with chronic disease
n = 87
Pa Pb
SV (mL)
Overall 82.6 (53.9–112.9) 0.093 78.4 (56.9–112.3) 0.237 0.052
61–70 years 84.8 (58.5–112.8) 79.0 (60.9–107.6) 0.047 ⁎
71–80 years 79.4 (51.9–105.9) 78.8 (58.5–115.0) 0.588
N80 years 78.9 (64.5–103.4) 75.7 (57.4–101.0) 0.141
SVI (mL·m−2)
Overall 53.6 (35.5–70.4) 0.963 50.1 (35.5–69.5) 0.727 0.056
61–70 years 53.8 (36.7–70.3) 50.0 (37.5–64.5) 0.105
71–80 years 53.6 (36.7–70.4) 49.7 (35.8–69.4) 0.218
N80 years 53.0 (37.4–66.8) 52.2 (35.4–69.1) 0.821
CO (L·min−1)
Overall 5.2 (3.6–7.3) 0.757 5.0 (3.4–7.0) 0.535 0.267
61–70 years 5.3 (3.7–7.0) 5.1 (3.4–6.5) 0.346
71–80 years 5.1 (3.7–8.0) 5.1 (3.6–7.0) 0.978
N80 years 5.2 (4.3–6.0) 4.7 (3.7–6.4) 0.365
CI (L·min−1·m−2)
Overall 3.2 (2.3–4.7) 0.553 3.1 (2.2–4.5) 0.512 0.164
61–70 years 3.2 (2.1–4.5) 3.1 (2.4–4.0) 0.221
71–80 years 3.3 (2.3–5.4) 3.1 (2.2–4.6) 0.163
N80 years 3.4 (2.7–3.7) 3.3 (2.5–4.2) 0.497
SVR (d·s·cm−5)
Overall 1481 (980–2106) 0.545 1553 (1128–2606) 0.446 0.080
61–70 years 1438 (1103–1967) 1576 (1178–2238) 0.051
71–80 years 1590 (943–2307) 1508 (1175–2359) 0.957
N80 years 1627 (1231–1863) 1655 (1133–2454) 0.497
SVRI (d·s·cm−5·m2)
Overall 2515 (1527–3507) 0.755 2512 (1812–4061) 0.616 0.084
61–70 years 2495 (1686–3500) 2662 (1983–3769) 0.057
71–80 years 2515 (1342–3607) 2455 (1873–4015) 0.239
N80 years 2652 (2079–3191) 2485 (1722–3653) 0.821
Legend to Table 2.
Data presented as medians (2.5th–97.5th percentiles).
a Comparison between age groups.
b Comparison between subjects without (ASA 1) and with (ASA 2) chronic disease.
⁎ = statistically signiﬁcant.
52 C.P. Chan et al. / BBA Clinical 2 (2014) 48–55
Table 4
Comparison of hemodynamic parameters in males and females without chronic disease
(ASA 1) (n = 78).
Parameter Unit Males Females P
Preload
FT ms 396 (321–462) 410 (330–449) 0.267
FTc ms 405 (312–458) 418 (358–447) 0.094
SVV % 17.2 (11.4–30.0) 16.4 (8.6–29.6) 0.001⁎
Contractility
HR bpm 63.8 (46.9–89.8) 62.7 (50.2–79.7) 0.948
VTI m 26.9 (20.9–34.2) 30.0 (20.4–38.5) 0.173
Vpk m·s−1 1.1 (0.9–1.4) 1.2 (0.9–1.6) 0.012⁎
ET % 41.7 (34.4–52.9) 43.1 (33.9–50.7) 0.308
SV mL 82.4 (63.0–112.5) 82.8 (53.0–106.7) 0.001⁎
SVI mL·m−2 48.3 (35.9–65.4) 55.8 (36.0–70.5) 0.430
SMII W·m−2 1.7 (1.2–2.5) 1.8 (1.1–2.3) 0.379
Pmn mm Hg 2.2 (1.4–3.6) 2.5 (1.4–4.3) 0.011⁎
MD m·min−1 17.1 (13.1–27.2) 19.0 (14.1–25.3) 0.009⁎
SW mJ 1083 (690–1623) 985 (674–1421) 0.736
CP W 1.1 (0.7–1.7) 1.0 (0.7–1.5) 0.121
Afterload
PKR 50.2 (31.0–76.7) 38.4 (22.4–86.7) 0.001⁎
SVR d.s.cm−5 1548 (989–1967) 1449 (1023–2204) 0.655
SVRI d.s.cm−5 m2 2630 (1557–3401) 2024 (1507–3661) 0.003⁎
Tissue perfusion
CO L·min−1 5.3 (4.1–7.7) 5.1 (3.6–6.8) 0.448
CI L·min−1·m−2 3.0 (2.3–5.3) 3.5 (2.3–4.6) 0.004⁎
DO2 mL·min−1 845 (390–1335) 751 (517–1133) 0.076
DO2I mL·min−1·m−2 520 (244–899) 524 (358–761) 0.577
Legend to Table 4.
Data presented as medians (2.5th–97.5th percentiles).
⁎ = statistically signiﬁcant.
53C.P. Chan et al. / BBA Clinical 2 (2014) 48–55sectional area around 21% greater than the aortic valve. As the vol-
ume ﬂow through both is the same, then the velocity of ﬂow will
be around 18% lower through the pulmonary valve than through
the aortic valve.
4.2. Sex differences
In this study, relative to males, females showed similar values
for SV but lower values for BSA. Consequently, SVI and CI were
higher in females. Absolute SV and CO were higher in American
Indian males than females, whereas normalization for BSA elimi-
nated the sex difference in SV and resulted in slightly higher CI
in females [13]. SV and CO normalized for fat-free body mass
(FFM) were considerably higher in females than males. There
was no signiﬁcant difference in absolute values for SVR in the cur-
rent study, but females had lower SVRI values as a result of their
lower BSA. Females had lower haemoglobin concentrations
(P b 0.001) and, as a consequence of their smaller size, smaller
valve diameters (P b 0.001) than males. They would therefore be
expected to show higher ejection velocities, with higher Pmn,
MD and Vpk. The increased velocity of ejection leads to a higher
value for kinetic energy, which is the divisor in the PKR calculation
(PKR = PE / KE) resulting in a lower value for PKR. The differences
between the sexes shown in Table 4 are therefore entirely physio-
logical and anatomical and are expected.
4.3. Study limitations
Firstly, the number of subjects aged over 80 years both with
and without chronic disease was small (9 and 16 respectively).
However, this number is greater than in previously reportedstudies [3,4,6,24]. There were only nine patients in the ASA 1
group and seven of these were male. This could explain why the
average height is signiﬁcantly different. Conversely, in the ASA 2
group, only ﬁve of the 16 were male could have skewed the height
data in the opposite direction. The ﬁgures for the 61 to 70 group
and 71 to 80 group are much more evenly balanced. Secondly,
the subjects were classiﬁed as ASA 1 (a normal healthy subject)
and ASA 2 (a patient with mild systemic disease) according to
the American Society of Anesthesiology grading. The deﬁnition is
broad. However, this system has been well validated and is univer-
sally known and accepted. The use of a health questionnaire and
direct questioning of the subject is a recognised standard for ASA
grading. Given the large number of potential conditions which
could be present in this age group, it is simply a pragmatic way
of deﬁning them. Thirdly, as the reference ranges were deﬁned
using 2.5th and 97.5th percentiles to include 95% of the popula-
tion, there is a 5% possibility that an otherwise normal subject
may have an USCOM measurement that lies outside the reference
ranges, but this applies to all variables. In addition, although the
CVP was assumed to be zero for calculation of MAP–CVP in this
study, which in turn affects cardiac power (CP), SW, SVR, SVRI,
SMII and PKR, the likely effect on these variables is minimal. In
percentage terms, the differences in these haemodynamic parame-
ters would be typically 1.5%, 3.0% and 6.0% respectively for CVP
values of 5, 10 and 20 mm Hg. More signiﬁcantly, this study only
included subjects from Hong Kong. Our results may not be gener-
alizable to other parts of China, let alone elsewhere in the world.
Nevertheless, they are the ﬁrst published data for this technique
in any elderly ethnic group.
We believe itwould be appropriate to extend this studywith a larger
sample size for those aged over 80 years, particularly as so many Chi-
nese and other races are now living to this age and beyond. A multina-
tional study is also indicated to explore the differences between races as
suggested by studies from theUnited States, Australia and Sweden.Only
then could the true generalizability or otherwise of our results be
established.
5. Conclusion
This study showed no adverse effects of ageing on resting
haemodynamics. There were no signiﬁcant differences in resting
haemodynamics between healthy (ASA 1) and mild chronic dis-
ease (ASA 2) subjects. There were no clinically signiﬁcant differ-
ences between haemodynamic measurements from the aortic
valve as opposed to the pulmonary valve; the two are interchange-
able in terms of indexed values. Reference ranges for 21 haemody-
namic parameters measured by USCOM in Chinese adults (but not
for non-Chinese populations) aged over 60 years have been
established.
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54 C.P. Chan et al. / BBA Clinical 2 (2014) 48–55Appendix 1. Haemodynamic parameters measured or calculated by USCOM [19,35].Parameter Unit Deﬁnition/equation
Preload
Flow time (FT) ms Systolic ejection time
Flow time corrected (FTc) ms FTc = FT / √R–R interval
Stroke volume variation (SVV) % SVV = (SVmax − SVmin × 100) / [(SVmax + SVmin) / 2]
Contractility
Heart rate (HR) bpm Number of cardiac cycles in beats per min
Velocity time integral (VTI) m TI = ∫ 0FTV(t)dt
Peak ejection velocity (Vpk) m·s−1 Maximum ejection velocity through valve
Ejection time (ET) % ET% = (ET / cycle duration) × 100
Stroke volume (SV) mL SV = vti × πr2
Stroke volume index (SVI) mL·m−2 SVI = SV / BSA
Smith–Madigan inotropy index (SMII) W·m−2 SMII = (PE + KE) / BSA
Mean pressure gradient (Pmn) mm Hg Pmn = 4 × Vmean2
Minute distance (MD) m·min−1 MD = HR × vti
Stroke work (SW) mJ SW = (60/450) (MAP–CVP) × SV
Cardiac power (CP) W CP = (MAP–CVP) × CO / 450.037
Afterload
Potential to kinetic energy ratio (PKR) PKR = PE / KE
PE = (ΔP × SV × 10−3) / (7.5 × FT)
KE = (SV × 10−6 × ρ × Vm2) / (2 × FT)
Systemic vascular resistance (SVR) d·s·cm−5 SVR = (MAP−CVP) x 80/CO
Systemic vascular resistance index (SVRI) d·s·cm−5·m2 SVRI = SVR × BSA
Tissue perfusion
Cardiac output (CO) L·min−1 CO = SV × HR
Cardiac index (CI) L·min−1.m-2 CI = CO / BSA
Oxygen delivery (DO2) mL·min−1 DO2 = 1.34 × Hb × SpO2 / 100 × CO
Oxygen delivery index (DO2I) mL·min−1·m−2 DO2I = DO2 / BSA
BSA: body surface area (m2); CVP: central venouspressure (mm Hg);Hb: haemoglobin concentration (g·L−1);MAP:mean arterial pressure (mm Hg); SpO2: peripheral oxygen saturation
(%); R–R interval: heart beat periodicity (s); Vm: mean velocity (m·s−1); ρ: density of blood (kg·m−3); ΔP: MAP–CVP (mm Hg); πr2: cross-sectional area of outﬂow tract (m2).References
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